AI that turns your R&D data into answers.

Choose how to investigate your data, and Omabit runs the analysis and writes it up. Used by pharma and biotech teams, from the lab to Phase 2 trials.

Works with your data

Preclinical, clinical and diagnostics.

29%

of drugs in Phase 2 reach Phase 3.

57%

of the $2.6 billion it costs to develop a drug goes to clinical trials.

spent on clinical trials since you opened this page.

Choose what to investigate. Omabit runs the analysis, checks it against published research and writes it up.

Our security controls and SOC 2 progress are in our trust center.

Infrastructure SOC 2 aligned, encrypted in transit and at rest

Data location You choose where your data lives: our cloud or yours

Access Per-project keys, audit logs, SSO on request

Retention You set retention windows per dataset

Clinical development teams

Plan the next trial from what the last one showed.

Biomarker and translational teams

Find the patients who respond, and the biology behind it.

Biostatistics teams

Get routine analyses done without writing new code.

Research scientists

Analyze new experiments alongside past ones.